Get started
Author

Barbora Vakrmanová

Observed names: B. Vakrmanova, Barbora Cabalkova Vakrmanova, Barbora Vakrmanova, Vakrmanová, Barbora
ORCID: 0000-0002-1716-1199
Observed ORCID: 0000-0002-1716-1199
OpenAlex ID: A5058498765
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
2021 · Sheena Mukkada, Nickhill Bhakta, et al. · The Lancet Oncology · 132
PDF
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
2018 · Ondrej Hrusak, Valerie de Haas, et al. · Blood · 112
PDF
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch
2020 · Michaela Novakova, Marketa Zaliova, et al. · Haematologica · 74
PDF
CD38: A target in relapsed/refractory acute lymphoblastic leukemia—Limitations in treatment and diagnostics
2022 · Barbora Vakrmanová, Michaela Nováková, et al. · Pediatric Blood & Cancer · 12
Switching Towards Monocytic Lineage and Discordancy between Flow Cytometric and PCR Minimal Residual Disease Results Is a Hallmark Feature of DUX4 Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia
2018 · Michaela Novakova, Barbora Vakrmanova, et al. · Blood · 3
Faculty Opinions recommendation of Genetic inactivation of CD33 in hematopoietic stem cells to enable CAR T cell immunotherapy for acute myeloid leukemia.
2018 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2
P376: Cd38: a Functioning Target in Relapsed/refractory Acute Lymphoblastic Leukemia. Limitations in Treatment and Diagnostics.
2022 · B. Vakrmanova, M. Novakova, et al. · HemaSphere · 1
Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment
2020 · Barbora Vakrmanova, Eva Fronkova, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Pf176 Monocytic Switch and Discrepancy Between Flow Cytometric and Molecular Minimal Residual Disease Are Frequent in Dux4 Rearranged and Pax5‐p80r Mutated B‐cell Precursor Acute Lymphoblastic Leukemia
2019 · M. Novakova, B. Vakrmanova, et al. · HemaSphere · 1
Late Effects of Immunosuppressive Therapy in Acquired Bone Marrow Failure: Long-term Follow-up of Czech Patients With Aplastic Anemia and Refractory Cytopenia
2025 · Martina Sukova, Barbora Cabalkova Vakrmanova, et al. · EJC Paediatric Oncology
PDF
Infant Extramedullary Kmt2a Rearranged T/myeloid Acute Leukemia Mimicking Langerhans Cell Histiocytosis
2023 · Barbora Vakrmanova, Ester Mejstrikova, et al. · EJC Paediatric Oncology
PDF
Lineage plasticity of leukemic blasts. Importance for detection of minimal residual disease and study of hematopoesis
2022 · Vakrmanová, Barbora · Digital Repository (National Repository of Grey Literature)
Faculty Opinions recommendation of IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Concomitant use of a dual ABL/Src kinase inhibitor eliminates the in vitroefficacy of blinatumomab against Ph+ ALL.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: A report from the children's oncology group.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Ruxolitinib for Refractory/Relapsed Hemophagocytic Lymphohistiocytosis.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
PDF
Faculty Opinions recommendation of Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Bi-specific and Split CAR T Cells Targeting CD13 and TIM3 Eradicate Acute Myeloid Leukemia.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study.
2020 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
2019 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity.
2019 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM.
2019 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.
2019 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Faculty Opinions recommendation of Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation.
2019 · Jan Starý, Barbora Vakrmanova · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Works count: 37
Citation count: 338
H-index: 4
I10-index: 4
Year
Topic
Type